Antibody persistence was calculated for the ATP cohorts for persistence, which included all eligible children vaccinated with MMR-RIT or M-M-R II, who complied with blood sampling schedules, and who had immunogenicity measurements available for pre-vaccination, Day 42 and Year 2 post-vaccination
Antibody persistence was calculated for the ATP cohorts for persistence, which included all eligible children vaccinated with MMR-RIT or M-M-R II, who complied with blood sampling schedules, and who had immunogenicity measurements available for pre-vaccination, Day 42 and Year 2 post-vaccination. The percentage of children with antibody concentrations 200mIU/mL (measles), 10 IU/mL (rubella), 4 ED50(mumps,…